首站-论文投稿智能助手
典型文献
Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines
文献摘要:
Traditional medicine has provided a basis for health care and disease treatment to Chinese people for millennia,and herbal medicines are regulated as drug products in China.Chinese herbal medicines have two features.They normally possess very complex chemical composition.This makes the identification of the constituents that are together responsible for the therapeutic action of an herbal medicine challenging,because how to select compounds from an herbal medicine for pharmacodynamic study has been a big hurdle in such identification efforts.To this end,a multi-compound pharmacokinetic approach was established to identify potentially important compounds(bioavailable at the action loci with significant exposure levels after dosing an herbal medicine)and to characterize their pharmacokinetics and disposition.Another feature of Chinese herbal medicines is their typical use as or in combination therapies.Coadministration of complex natural products and conventional synthetic drugs is prevalent worldwide,even though it remains very controversial.Natural product-drug interactions have raised wide concerns about reduced drug efficacy or safety.However,growing evidence shows that incorporating Chinese herbal medicines into synthetic drug-based therapies delivers benefits in the treatment of many multifactorial diseases.To address this issue,a drug-combination pharmacokinetic approach was established to assess drug-drug interaction potential of herbal medicines and degree of pharmacokinetic compatibility for multi-herb combination and herbal medicine-synthetic drug combination therapies.In this review we describe the methodology,techniques,requirements,and applications of multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines and to discuss further development for these two types of pharmacokinetic research.
文献关键词:
作者姓名:
Chuan Li;Wei-wei Jia;Jun-ling Yang;Chen Cheng;Olajide E.Olaleye
作者机构:
State Key Laboratory of Drug Research,Shanghai Institute of Materia Medica,Chinese Academy of Sciences,Shanghai 201203,China
引用格式:
[1]Chuan Li;Wei-wei Jia;Jun-ling Yang;Chen Cheng;Olajide E.Olaleye-.Multi-compound and drug-combination pharmacokinetic research on Chinese herbal medicines)[J].中国药理学报(英文版),2022(12):3080-3095
A类:
Coadministration
B类:
Multi,combination,research,Chinese,herbal,medicines,Traditional,has,provided,basis,health,care,treatment,people,millennia,regulated,products,China,have,two,features,They,normally,possess,very,complex,chemical,composition,This,makes,identification,constituents,that,together,responsible,therapeutic,challenging,because,select,compounds,from,pharmacodynamic,study,been,big,hurdle,such,efforts,To,this,end,approach,was,established,identify,potentially,important,bioavailable,loci,significant,exposure,levels,after,dosing,characterize,their,pharmacokinetics,disposition,Another,typical,therapies,natural,conventional,synthetic,drugs,prevalent,worldwide,even,though,remains,controversial,Natural,interactions,raised,concerns,about,reduced,efficacy,safety,However,growing,evidence,shows,incorporating,into,delivers,benefits,many,multifactorial,diseases,address,issue,assess,degree,compatibility,In,review,describe,methodology,techniques,requirements,applications,discuss,further,development,these,types
AB值:
0.48836
相似文献
Use of complementary and alternative medicine in general population during COVID-19 outbreak:A survey in Iran
Mahlagha Dehghan;Alireza Ghanbari;Fatemeh Ghaedi Heidari;Parvin Mangolian Shahrbabaki;Mohammad Ali Zakeri-Nursing,Research Center,Kerman University of Medical Sciences,Kerman 76169-13555,Iran;Department of Critical Care Nursing,Faculty of Nursing and Midwifery,Kerman University of Medical Sciences,Kerman 76169-13555,Iran;Anesthesiology and Critical Care Research Center,Shiraz University of Medical Sciences,Shiraz 14336-71348,Iran;Faculty of Nursing and Midwifery,Isfahan University of Medical Sciences,Isfahan 81746-73461,Iran;Non-communicable Diseases Research Center,Rafsanjan University of Medical Sciences,Rafsanjan 77179-33777,Iran;Social Determinants of Health Research Center,Rafsanjan University of Medical Sciences,Rafsanjan 77179-33777,Iran
Schaftoside inhibits 3CLpro and PLpro of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19
Yang Yi;Meng Zhang;Heng Xue;Rong Yu;Yang-Oujie Bao;Yi Kuang;Yue Chai;Wen Ma;Jing Wang;Xiaomeng Shi;Wenzhe Li;Wei Hong;Junhua Li;Elishiba Muturi;Hongping Wei;Joachim Wlodarz;Szczepan Roszak;Xue Qiao;Hang Yang;Min Ye-State Key Laboratory of Natural and Biomimetic Drugs,School of Pharmaceutical Sciences,Peking University,Beijing 100191,China;CAS Key Laboratory of Special Pathogens and Biosafety,Center for Biosafety Mega-Science,Wuhan Institute of Virology,Chinese Academy of Sciences,Wuhan 430071,China;University of Chinese Academy of Sciences,Beijing 100049,China;Faculty of Science and Technology,University of Silesia,Katowice 40-007,Poland;Department of Physical and Quantum Chemistry,Faculty of Chemistry,Wroclaw University of Science and Technology,Wroclaw 50-370,Poland
机标中图分类号,由域田数据科技根据网络公开资料自动分析生成,仅供学习研究参考。